Kawanishi, Japan

Mikiko Hamaguchi


Average Co-Inventor Count = 5.2

ph-index = 2

Forward Citations = 15(Granted Patents)


Location History:

  • Hyogo, JP (1991)
  • Kawanishi, JP (1993 - 1995)

Company Filing History:


Years Active: 1991-1995

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Mikiko Hamaguchi: Innovator in Pyrroloazepine Derivatives

Introduction

Mikiko Hamaguchi is a prominent inventor based in Kawanishi, Japan. She has made significant contributions to the field of medicinal chemistry, particularly in the development of pyrroloazepine derivatives. With a total of 4 patents to her name, her work focuses on innovative therapeutic solutions.

Latest Patents

Hamaguchi's latest patents include pyrroloazepine derivatives that exhibit anti-α1 activity and anti-serotonin activity. These compounds are represented by a specific chemical formula, where R can be a hydrogen atom or various alkyl groups. Additionally, she has developed pyrroloazepine derivatives that are useful in treating circulatory diseases, also represented by a similar chemical structure. The preparation processes for these derivatives are disclosed in her patents, showcasing her commitment to advancing therapeutic options.

Career Highlights

Mikiko Hamaguchi is currently employed at Suntory Limited, a well-known company in the beverage and pharmaceutical industries. Her work at Suntory has allowed her to focus on innovative research and development in the field of medicinal chemistry.

Collaborations

Throughout her career, Hamaguchi has collaborated with notable colleagues, including Hidetsura Cho and Akira Mizuno. These collaborations have contributed to her success and the advancement of her research.

Conclusion

Mikiko Hamaguchi is a distinguished inventor whose work in pyrroloazepine derivatives has the potential to impact therapeutic practices significantly. Her contributions to medicinal chemistry continue to pave the way for innovative solutions in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…